Therefore, considering the importance of JNK3 and the failure of MLK and JNK inhibitors to treat PD, identifying potent specific inhibitors of JNK3 may allow for the protection of dopaminergic neurons in PD. This evidence concerns the gene MAPK8 and Parkinson disease.